Molly Henderson

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Princeton, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Molly Henderson
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Molly Henderson

Form 4 holding Chief Financial Officer

UroGen Pharma Ltd.

Security class
Ordinary Shares
Shares / value
5,248
Estimated value
$94,516
Report date
31 Jan 2022
Price
$18.01
Ownership
Direct
Form 4 holding CFO and CBO

Phathom Pharmaceuticals, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
50,000
Estimated value
Report date
27 Feb 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

UroGen Pharma Ltd.

Security class
Stock Option (right to buy)
Shares / value
30,000
Estimated value
Report date
31 Jan 2022
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Chief Financial Officer

UroGen Pharma Ltd.

Security class
Restricted Stock Units
Shares / value
7,500
Estimated value
Report date
31 Jan 2022
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by Molly Henderson

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .